Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
2.400
-0.210 (-8.05%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Can-Fite BioPharma Revenue

In the year 2023, Can-Fite BioPharma had annual revenue of $743.00K, a decrease of -8.27%.

Revenue (ttm)
$743.00K
Revenue Growth
-12.90%
P/S Ratio
17.84
Revenue / Employee
$92,875
Employees
8
Market Cap
13.25M USD

Revenue Chart

* The company reports in ILS currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023743.00K-67.00K-8.27%
Dec 31, 2022810.00K-43.00K-5.04%
Dec 31, 2021853.00K90.00K11.80%
Dec 31, 2020763.00K-1.27M-62.45%
Dec 31, 20192.03M-1.79M-46.81%
Dec 31, 20183.82M3.03M384.16%
Dec 31, 2017789.00K624.00K378.18%
Dec 31, 2016165.00K3.00K1.85%
Dec 31, 2015162.00K--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Dec 31, 2011481.95K-231.93K-32.49%
Dec 31, 2010713.88K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
China Jo-Jo Drugstores 154.66M
TRxADE HEALTH 6.66M
BIMI International Medical 5.85M
QT Imaging Holdings 1.40M
Talis Biomedical 989.00K
Talphera 651.00K
Revenue Rankings